Phibro Animal Health Corporation (PAHC) — Analyst outlook / Analyst consensus target is. Based on 13 analyst ratings, the consensus is bullish — 6 Buy, 3 Hold, 4 Sell.
The consensus price target is $49.00, representing a downside of 17% from the current price $59.02.
Analysts estimate Earnings Per Share (EPS) of $1.12 and revenue of $1.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $0.06 vs est $1.12 (missed -94.7%). 2025: actual $1.19 vs est $2.03 (missed -41.5%). Analyst accuracy: 0%.
PAHC Stock — 12-Month Price Forecast
$49.00
▼ -16.98% Downside
Average Price Target
Based on 13 Wall Street analysts offering 12-month price targets for Phibro Animal Health Corporation, the price target is $49.00.
The average price target represents a -16.98% change from the last price of $59.02.
PAHC Analyst Ratings
Buy
Based on 13 analysts giving stock ratings to Phibro Animal Health Corporation in the past 3 months
EPS Estimates — PAHC
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.06
vs Est $1.12
▼ 1,779.2% off
2025
Actual $1.19
vs Est $2.03
▼ 70.8% off
Profitability Outlook
Company is profitable but with thin earnings per share. EPS trend is improving.
Revenue Estimates — PAHC
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $1.018B
vs Est $1.003B
▲ 1.5% off
2025
Actual $1.296B
vs Est $1.278B
▲ 1.4% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
